NASDAQ:NVDQ - (NVDQ) Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$11.75
+0.30 (1.20%)
Get New (NVDQ) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NVDQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NVDQ

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for (NVDQ) in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $11.75.

This chart shows the closing price for NVDQ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in (NVDQ). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/31/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/27/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/1/2017Royal Bank of CanadaReiterated RatingHold$11.75N/A
9/1/2017Canaccord GenuityReiterated RatingHold$11.75Low
8/14/2017Northland SecuritiesReiterated RatingHold$11.75Medium
7/13/2017JMP SecuritiesReiterated RatingOutperform ➝ Market PerformLow
7/13/2017Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$12.00 ➝ $11.75Low
7/10/2017Canaccord GenuityDowngradeBuy ➝ Hold$11.75Low
6/20/2017First AnalysisDowngradeOverweight ➝ Equal WeightLow
6/20/2017ScotiabankLower Price TargetOutperform$15.50 ➝ $13.25Low
6/20/2017Stifel NicolausDowngradeBuy ➝ Hold$11.75Low
6/19/2017Canaccord GenuityReiterated RatingBuy$10.00Low
6/19/2017Craig HallumDowngradeBuy ➝ Hold$11.75Low
6/19/2017WedbushDowngradeOutperform ➝ NeutralN/A
6/19/2017Northland SecuritiesReiterated RatingHold$11.75N/A
6/2/2017Stifel NicolausReiterated RatingBuy$10.00High
5/4/2017ScotiabankReiterated RatingOutperform$18.00High
4/26/2017ScotiabankReiterated RatingOutperform$18.00Low
3/13/2017Northland SecuritiesUpgradeUnder Perform ➝ Market Perform$7.00Medium
3/1/2017Feltl & Co.DowngradeBuy ➝ HoldN/A
3/1/2017Stifel NicolausLower Price TargetBuy$16.00 ➝ $10.00N/A
3/1/2017Royal Bank of CanadaSet Price TargetBuy$13.00 ➝ $12.00N/A
2/22/2017Canaccord GenuityReiterated RatingBuy$10.00N/A
2/6/2017Canaccord GenuityReiterated RatingBuy$10.00N/A
1/17/2017Craig HallumSet Price TargetBuy$12.00N/A
1/12/2017Canaccord GenuityReiterated RatingBuy$15.00 ➝ $10.00N/A
1/11/2017William BlairDowngradeOutperform ➝ Market PerformN/A
1/11/2017Royal Bank of CanadaSet Price TargetOutperform$16.00 ➝ $13.00N/A
1/11/2017Royal Bank of CanadaLower Price TargetOutperform$16.00 ➝ $13.00N/A
1/11/2017WedbushReiterated RatingOutperform$17.00 ➝ $11.00N/A
12/1/2016JMP SecuritiesReiterated RatingBuyN/A
11/16/2016BTIG ResearchReiterated RatingHoldN/A
11/15/2016WedbushReiterated RatingOutperform$17.00N/A
11/6/2016JMP SecuritiesReiterated RatingBuyN/A
11/3/2016Feltl & Co.DowngradeStrong-Buy ➝ BuyN/A
11/3/2016Noble FinancialDowngradeStrong-Buy ➝ BuyN/A
(Data available from 10/24/2016 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/28/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/27/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/26/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/24/2021

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
(NVDQ) logo
NOVADAQ Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The SPY Fluorescence Imaging platform can be used to develop imaging devices specifically designed to meet the needs of different surgeons and other healthcare providers and the specialty procedures they perform. SPY images enable physicians treating life-threatening illnesses, such as breast, head and neck, colon, complex hernias, diabetes and certain cardiovascular diseases.
Read More

Today's Range

Now: $11.75
Low: $11.75
High: $11.75

50 Day Range

MA: N/A

52 Week Range

Now: $11.75
Low: $5.84
High: $12.74

Volume

N/A

Average Volume

797,205 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of (NVDQ)?

The following Wall Street sell-side analysts have issued stock ratings on (NVDQ) in the last year:
View the latest analyst ratings for NVDQ.

What is the current price target for (NVDQ)?

0 Wall Street analysts have set twelve-month price targets for (NVDQ) in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for (NVDQ) in the next year.
View the latest price targets for NVDQ.

What is the current consensus analyst rating for (NVDQ)?

(NVDQ) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for NVDQ.

How do I contact (NVDQ)'s investor relations team?

(NVDQ)'s physical mailing address is 5090 Explorer Dr Suite 202, MISSISSAUGA, ON L4W 4T9, Canada. The medical research company's listed phone number is +1-905-6293822. The official website for (NVDQ) is novadaq.com.